- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Product Name | Swiss Prot# | Size | Price (US$) | Order |
PN1185 | Recombinant Protein-Modoc virus NS5 protein (a.a.31 to 337) | O55811 | 100 µg | 1195 | |
PN1186 | Recombinant Protein-Modoc virus NS3 protein (a.a.31 to 357) | Q71SH4 | 100 µg | 1195 | |
PN1187 | Recombinant Protein-Modoc virus capsid protein (a.a.2 to 110) | Q8QL64 | 100 µg | 1195 | |
PN1188 | Recombinant Protein-Modoc virus matrix protein (a.a.198 to 272) | Q8QL64 | 100 µg | 1195 | |
PN1189 | Recombinant Protein-Modoc virus envelope protein (a.a.273 to 754) | Q8QL64 | 100 µg | 1195 | |
PN1190 | Recombinant Protein-Modoc virus non-structural protein 1 (a.a.755 to 1107) | Q8QL64 | 100 µg | 1195 | |
RPN1185 | cDNA-Modoc virus NS5 protein (a.a.31 to 337) | O55811 | 2 µg | 1530 | |
RPN1186 | cDNA-Modoc virus NS3 protein (a.a.31 to 357) | Q71SH4 | 2 µg | 1630 | |
RPN1187 | cDNA-Modoc virus capsid protein (a.a.2 to 110) | Q8QL64 | 2 µg | 800 | |
RPN1188 | cDNA-Modoc virus matrix protein (a.a.198 to 272) | Q8QL64 | 2 µg | 800 | |
RPN1189 | cDNA-Modoc virus envelope protein (a.a.273 to 754) | Q8QL64 | 2 µg | 2405 | |
RPN1190 | cDNA-Modoc virus non-structural protein 1 (a.a.755 to 1107) | Q8QL64 | 2 µg | 1760 |
Modoc virus cDNA and recombinant antigen
Modoc virus is a newly discovered virus in the genus Orthonairovirus of the family Nairoviridae. It was first identified in 2013 in the tissues of a loggerhead sea turtle in the Atlantic Ocean but has since been found in a variety of wildlife species including birds, bats, and rodents. The virus is named after the Modoc Plateau in California, where it was first detected in bats. The pathogenesis and clinical significance of Modoc virus in wildlife and humans is not well understood, but it is known to cause disease in some species of animals. Further research is needed to fully understand the epidemiology and potential public health implications of this virus.
The Modoc virus has antigens that trigger an immune response in infected organisms. Antigens can be proteins or sugars on the virus surface. Identifying these antigens can help develop diagnostic tests, vaccines, and treatment. Techniques like protein purification, serological assays, and molecular biology can be used to isolate and identify Modoc virus antigens. Knowing the antigen composition is crucial for controlling the virus and preventing public health impact.
The Modoc virus genome is a RNA molecule that carries the genetic information necessary for the replication and survival of the virus. The exact size and structure of the Modoc virus genome are not well known, but it is believed to be similar to other members of the Nairoviridae family. The genomic information of the Modoc virus can be used to understand its biology, pathogenesis, and evolution, and can also aid in the development of diagnostic tests, vaccines, and antiviral treatments. The discovery of the Modoc virus genome has added to the growing body of knowledge about the diversity and distribution of emerging viruses and highlights the need for ongoing surveillance and research to better understand the potential public health impact of this virus. The virus encodes several important proteins, including:
NS5 protein: a non-structural protein that plays a key role in viral replication.
NS3 protein: another non-structural protein that is involved in viral replication and assembly.
Capsid protein: a structural protein that forms the viral capsid.
Matrix protein: a structural protein that lines the inner surface of the viral envelope.
Envelope protein: a structural protein that forms the outer layer of the virus and is responsible for viral entry into host cells.
Non-structural protein 1: a protein that plays a role in viral replication and may also modulate host immune responses.
These proteins play crucial roles in the virus life cycle, and understanding their functions is important for the development of effective strategies to prevent and treat Modoc virus infections. Ongoing research is focused on identifying potential targets for antiviral drug development and vaccine design.
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple